Haemonetics (NYSE:HAE) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $1.27 by 1.57 percent. This is a 4.03 percent increase over earnings of $1.24 per share from the same period last year. The company reported quarterly sales of $346.351 million which beat the analyst consensus estimate of $336.862 million by 2.82 percent. This is a 4.76 percent increase over sales of $330.599 million the same period last year.